Risk Factors for Bullous Pemphigoid in the Elderly: A Prospective Case–Control Study

2010/10/14 by Sylvie Bastuji-Garin, Sylvie Bastuji‐Garin, P. Joly +23 · 300 citations
Medicine · #Autoimmune Bullous Skin Diseases #Bipolar disorder #Bullous pemphigoid #Case-control study #Coagulation, Bradykinin, Polyphosphates, and Angioedema #Confidence interval #Dementia #Disease #Immunology #Internal medicine #Medicine #Multivariate analysis #Odds ratio #Prospective cohort study #Risk factor #Urticaria and Related Conditions

paper · pdf · doi:10.1038/jid.2010.301

published in Journal of Investigative Dermatology 131(3), 637-643 (Elsevier BV)

openalex publication_date 2010/10/14 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• “Mini-mental state”

Cited by

• Specific causes of death in patients with bullous pemphigoid as measured by death certificate data: a retrospective cohort study. [europepmc]
• Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009. [europepmc]
• A population-based study of the association between bullous pemphigoid and neurologic disorders. [europepmc]
• Bullous pemphigoid in infants: characteristics, diagnosis and treatment. [europepmc]
• Autoantibodies to Collagen XVII Are Present in Parkinson's Disease and Localize to Tyrosine-Hydroxylase Positive Neurons. [europepmc]
• Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. [europepmc]
• Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients. [europepmc]
• The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations. [europepmc]
• Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature. [europepmc]
• Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients. [europepmc]
• Association of Dipeptidyl Peptidase 4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes. [europepmc]
• Bullous pemphigoid. [europepmc]
• Skin Barrier and Autoimmunity-Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin. [europepmc]
• Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology. [europepmc]
• Proteases in Pemphigoid Diseases. [europepmc]
• A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry. [europepmc]
• Resolution in bullous pemphigoid. [europepmc]
• Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis. [europepmc]
• Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment. [europepmc]
• The pathogenesis of bullous skin diseases. [europepmc]
• Bullous Pemphigoid: Trigger and Predisposing Factors. [europepmc]
• Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid: A Meta-analysis. [europepmc]
• Bullous Autoimmune Dermatoses–Clinical Features, Diagnostic Evaluation, and Treatment Options. [europepmc]
• Bullous pemphigoid: An immune disorder related to aging (Review). [europepmc]
• The association between Parkinson's disease and autoimmune diseases: A systematic review and meta-analysis. [europepmc]